GLPwatch
Trials (2139)
Page 7 of 36.
- A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver
- Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes
- Liraglutide Effects on Epicardial Fat Inflammatory Genes
- A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk
- Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS
- Post-Marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ozempic®
- The Lira Pump Trial
- Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?
- A Study of LY3502970 in Healthy Participants
- Liraglutide and Cardio-Metabolic Risk Markers
- SHAPE-ENDO: Pilot Randomized Trial of Multimodal Pre-Surgical Optimization Versus Standard Surgery in Patients With Obesity and Early-Stage Endometrial Cancer
- A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes
- Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study
- A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2)
- GLP-1 and Microvascular Function in Type 2 Diabetes
- Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 Diabetes
- Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass
- Effects of iGlarLixi Versus iGlar on Liver Fat Content in Patients With Type 2 Diabetes Mellitus Combined With Metabolic Dysfunction-associated Steatotic Liver Disease
- Effect of Gelofusine on GLP1-receptor Imaging
- A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)
- Pharmacology of Exenatide in Pediatric Sepsis
- Cardiovascular Outcomes SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists
- Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)
- A Research Study Comparing a New Medicine Oral Semaglutide to Placebo in People With Type 2 Diabetes
- A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec
- A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes
- Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)
- An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder
- Exendin-4 as a Treatment for Parkinson's Disease - Pilot Study
- Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control
- A Study of LY3437943 in Healthy Participants With a High Body Mass Index
- A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight
- Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes
- Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IGlarLixi
- A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants
- Liraglutide in Type 1 Diabetes
- Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients of South Asian Descent
- GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease
- The Effect of Semaglutide on Bone Health
- Pharmacological Postconditioning to Reduce Infarct Size Following Primary PCI
- GLP-1 Receptor Targeting in Diabetic and Healthy Individuals
- Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2D
- GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response
- Effects of Tirzepatide Plus Intensive Lifestyle Therapy on Body Weight and Metabolic Health in Latinos With Obesity
- Comparative Observation of Metabolic and Pharmacologic Adipose Remodeling With Enhanced Incretin AgonisTs
- A Research Study, Looking at How Xultophy® Works in People With Type 2 Diabetes in Local Clinical Practice in United Arab Emirates
- New Triple Combination Therapy in Newly Diagnosed Type 2 Diabetes
- GLP-1 Therapy After Bariatric Surgery in Chinese Patients With Obesity
- Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin
- Separate and Combined Extrapancreatic Effects of the Incretin Hormones
- GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac Surgery
- Liraglutide (Saxenda(R)) in Adolescents With Obesity After Sleeve Gastrectomy
- A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight
- Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)
- Liraglutide as add-on to Insulin in Type 1 Diabetes
- A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes
- The Effects of Exenatide on Post-Meal Sugar Peaks and Vascular Health in Obese/Pre-Diabetic Young Adults
- Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin
- Changes in Skin Autoflouresence Following Weight Loss and Maintenance Using Liraglutide in Knee Osteoarthritis
- A Study of Tirzepatide in Participants With Impaired Liver Function